CPhI Middle East 2026, held in Riyadh, is the region’s leading pharmaceutical trade fair and global industry hub. The next edition is scheduled for May 11–13, 2026, at the Riyadh Exhibition and Convention Centre in Malham.

At CPhI Middle East 2026, the exhibition spans the entire pharmaceutical value chain. Specifically, it showcases APIs, excipients, fine chemicals, natural extracts, and finished dosage forms. Additionally, it features contract services, biotechnology, pharma machinery, packaging, drug delivery systems, and processing technologies.

The event attracts a diverse, high-level visitor profile from across the pharmaceutical ecosystem. Notably, attendees include senior executives, decision-makers, regulators, procurement leaders, and R&D, manufacturing, and business development heads. Furthermore, it serves companies seeking to establish or expand operations in the MENA region.

CPhI Middle East 2026 provides strong opportunities for strategic partnerships between global suppliers and regional manufacturers. Moreover, it enables direct access to Saudi Arabia’s rapidly expanding pharmaceutical market. Consequently, participants can also reach broader MENA demand through one central platform. With growing local manufacturing, supported by regulatory incentives, the event becomes an ideal sourcing venue.

Key industries represented include pharma manufacturing, biotechnology, contract services, ingredients, equipment, packaging, and drug-delivery solutions. Finally, the exhibition reflects regional priorities: local production growth, biologics innovation, and increasing pharma supply-chain self-sufficiency.